The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ali, S.
Right arrow Articles by Kirby, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ali, S.
Right arrow Articles by Kirby, J. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*HEPARIN
The Journal of Immunology, 2005, 175: 1257-1266.
Copyright © 2005 by The American Association of Immunologists

A Non-Glycosaminoglycan-Binding Variant of CC Chemokine Ligand 7 (Monocyte Chemoattractant Protein-3) Antagonizes Chemokine-Mediated Inflammation1

Simi Ali2,*, Helen Robertson*, Julie H. Wain*, John D. Isaacs{dagger}, Ghada Malik* and John A. Kirby*

* The Applied Immunobiology and Transplantation Research Group and {dagger} The Musculoskeletal Research Group, Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom

A non-glycosaminoglycan (GAG)-binding variant of the pleiotropic chemokine CCL7 was generated by mutating to alanine the basic (B) amino acids within an identified 44BXBXXB49 GAG-binding motif. Unlike wild-type (wt) CCL7, the mutant sequence had no affinity for heparin. However, the mutant retained a normal affinity for CCR1, CCR2b, and CCR3, and produced a normal calcium flux in mononuclear leukocytes. Both the wt and mutant proteins elicited an equal leukocyte chemotactic response within a solute diffusion gradient but, unlike the wt protein, the mutant failed to stimulate cell migration across a model endothelium. The number of leukocytes recruited to murine air pouches by the mutant sequence was lower than that recruited by wt CCL7. Furthermore, the presence of a mixture of a mutant and wt CCL7 within the air pouch elicited no significant cell accumulation. Cell recruitment also failed using a receptor-sharing mixture of mutant CCL7 and wt CCL5 or a nonreceptor sharing mixture of mutant CCL7 and wt CXCL12. The potential of the mutant sequence to modulate inflammation was confirmed by demonstration of its ability to inhibit the chemotactic response generated in vitro by synovial fluid from patients with active rheumatoid arthritis. A further series of experiments suggested that the non-GAG-binding mutant protein could potentially induce receptor desensitization before, and at a site remote from, any physiological recognition of GAG-bound chemokines. These data demonstrate that GAG binding is required for chemokine-driven inflammation in vivo and also suggest that a non-GAG-binding chemokine receptor agonist can inhibit the normal vectorial leukocyte migration mediated by chemokines.




This article has been cited by other articles:


Home page
FASEB J.Home page
G. O'Boyle, P. Mellor, J. A. Kirby, and S. Ali
Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12
FASEB J, November 1, 2009; 23(11): 3906 - 3916.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Gupta, B. Fuchs, S. Schulz-Maronde, A. Heitland, S. E. Escher, M. Mack, H.-C. Tillmann, A. Braun, W.-G. Forssmann, J. Elsner, et al.
Intravascular inactivation of CCR5 by n-Nonanoyl-CC chemokine ligand 14 and inhibition of allergic airway inflammation
J. Leukoc. Biol., March 1, 2008; 83(3): 765 - 773.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
B. C. Timmons and M. Mahendroo
Processes Regulating Cervical Ripening Differ From Cervical Dilation and Postpartum Repair: Insights From Gene Expression Studies
Reproductive Sciences, December 1, 2007; 14(8_suppl): 53 - 62.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
J. R. Harvey, P. Mellor, H. Eldaly, T. W.J. Lennard, J. A. Kirby, and S. Ali
Inhibition of CXCR4-Mediated Breast Cancer Metastasis: A Potential Role for Heparinoids?
Clin. Cancer Res., March 1, 2007; 13(5): 1562 - 1570.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. V. Campanella, J. Grimm, L. A. Manice, R. A. Colvin, B. D. Medoff, G. R. Wojtkiewicz, R. Weissleder, and A. D. Luster
Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity
J. Immunol., November 15, 2006; 177(10): 6991 - 6998.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.